Doravirine + Lamivudine + Tenofovir

Trade Name:

Delstrigo

Manufacturer/Distributor:

Merck Canada Inc.

www.merck.ca

Classification:

Antiviral agent

Status:

active

Notice of Compliance (yyyy/mm/dd):

2018/11/09

Date Marketed in Canada (yyyy/mm/dd):

2018/12/15

Presentation:

Tablet: doravirine 100 mg, lamivudine 300 mg, tenofovir 300 mg. DIN: 02482592

Comments:

Three ingredient preparation for treatment of HIV-1 in adults without past or present evidence of viral resistance to doravirine, lamivudine, or tenofovir.

Keywords:

doravirine

Keywords:

lamivudine

Keywords:

tenofovir

Keywords:

aids

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Azilsartan	Edarbi	Antihypertensive agent	2013/03/27
Azilsartan + chlorthalidone	Edarbyclor	Antihypertensive agent	2013/03/27
Mirabegron	Myrbetriq	Genitourinary smooth muscle relaxant	2013/03/28
Nebivolol	Bystolic	Beta-blocker, cardioselective	2013/04
Ondansetron	Ondissolve ODF	Antiemetic	2013/04
Dimethyl fumarate	Tecfidera	Misc. central nervous system agent	2013/04
Linagliptin + metformin	Jentadueto	Oral antihyperglycemic agent	2013/04/17
Pertuzumab	Perjeta	Antineoplastic agent	2013/04/23
Saxagliptin + metformin	Komboglyze	Oral antihyperglycemic agent	2013/04/25
Enzalutamide	Xtandi	Antineoplastic agent	2013/06/07
Ulipristal acetate	Fibristal	Selective progesterone receptor modulator	2013/07/23
Guanfacine HCl	Intuniv XR	Alpha adrenergic receptor agonist for ADHD	2013/08/06
Perampanel	Fycompa	Anticonvulsant	2013/09/04
Rotigotine	Neupro	Antiparkinsonian agent / Dopamine agonist	2013/09/12
Trastuzumab emtansine	Kadcyla	Antineoplastic agent	2013/09/27
Levonorgestrel	Jaydess Intrauterine System	Progestogen	2013/11/01
Teriflunomide	Aubagio	Immunomodulator agent	2013/11/15
Pasireotide	Signifor	Synthetic analogue of somatostatin	2013/11/26
Pomalidomide	Pomalyst	Antineoplastic agent; immunmodulator	2014/02/24
Difluprednate	Durezol	Topical corticosteroid	2014/03/12
Brimonidine	Onreltea	alpha-2 adrenergic receptor antagonist for rosacea	2014/04/23
Linaclotide	Constella	Guanylate cyclase-C agonist	2014/05
Afatinib	Giotrif	Protein kinase inhibitor	2014/05/28
Canagliflozin	Invokana	antihyperglycemic agent	2014/06/25
Ethinyl estradiol + norethindrone	Lolo	Oral contraceptive	2014/07/03
Alogliptin	Nesina	Oral antihyperglycemic agent	2014/10/08
Alogliptin + metformin	Kazano	Oral antihyperglycemic agent	2014/10/08
Vortioxetine	Trintellix	Antidepressant	2014/10/28
Apremilast	Otezla	Immunosuppressant agent	2014/12/08
Stiripentol	Diacomit	Antiepileptic	2014/12/21
Siltuximab	Sylvant	Immunosuppressive agent	2015/01/02
Ledipasvir + sofosbuvir	Harvoni	Antiviral agent	2015/01/07
Vedolizumab	Entyvio	Immunosuppressive agent	2015/04/21
Ivermectin	Rosiver	Topical rosacea therapy	2015/05/25
Liraglutide	Saxenda	Incretin mimetic	2015/05/27
Tiotropium + olodaterol	Inspiolto Respimat	Bronchodilator combination - LAMA plus LABA	2015/05/29